Among the examined genes, the expression of CERS6 was significantly elevated in NSCLC (Figure 1B) and also shown to be associated with poor patient prognosis (Figure 1C) as well as lymph node metastasis (Table 1). The gene discussed is CERS6; the disease is non-small cell lung carcinoma.